4-Bromo-2-(5-bromo­thio­phen-2-yl)-1-[(5-bromo­thio­phen-2-yl)meth­yl]-5,6-dimethyl-1H-benzimidazole

The title compound, C(18)H(13)Br(3)N(2)S(2), was obtained via the reaction of N-bromo­succinamide with 5,6-dimethyl-2-(thio­phen-2-yl)-1-[(thio­phen-2-yl)meth­yl]-1H-benzimidazole. The compound exhibits rotational disorder of the 5-bromo­thio­phen-2-yl substituent with a refined major:minor occupanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Geiger, H. Cristina, Donohoe, James S., Geiger, David K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Union of Crystallography 2014
Materias:
Organic Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998606/
https://www.ncbi.nlm.nih.gov/pubmed/24826179
http://dx.doi.org/10.1107/S160053681400628X
Descripción
Sumario:The title compound, C(18)H(13)Br(3)N(2)S(2), was obtained via the reaction of N-bromo­succinamide with 5,6-dimethyl-2-(thio­phen-2-yl)-1-[(thio­phen-2-yl)meth­yl]-1H-benzimidazole. The compound exhibits rotational disorder of the 5-bromo­thio­phen-2-yl substituent with a refined major:minor occupancy ratio of 0.876 (7):0.124 (7). The 5-bromo­thio­phen-2-yl mean plane is canted to the benzimidazole plane by 20.0 (4) and 21 (4)° in the major and minor components, respectively. In the crystal, weak C—H⋯N inter­actions link the mol­ecules into infinite C(7) chains along the 2(1) axes.

Ejemplares similares